FDA Drug Application (202093) for TRANEXAMIC ACID by ACTAVIS LABS FL INC

Back to FDA Applications sponsored by ACTAVIS LABS FL INC

Application Number202093
Product Number001
FormTABLET;ORAL
Dosage650MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRANEXAMIC ACID
Active IngredientTRANEXAMIC ACID

Active IngredientCount
List of drugs with Active Ingredient TRANEXAMIC ACID3


Back to FDA Applications sponsored by ACTAVIS LABS FL INC